These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

246 related items for PubMed ID: 1664330

  • 1. Role of spinal kappa opioid receptors in the blockade of the development of antinociceptive tolerance to morphine.
    Takahashi M, Senda T, Kaneto H.
    Eur J Pharmacol; 1991 Aug 06; 200(2-3):293-7. PubMed ID: 1664330
    [Abstract] [Full Text] [Related]

  • 2. Effects of kappa-agonist on the antinociception and locomotor enhancing action induced by morphine in mice.
    Narita M, Takahashi Y, Takamori K, Funada M, Suzuki T, Misawa M, Nagase H.
    Jpn J Pharmacol; 1993 May 06; 62(1):15-24. PubMed ID: 8393497
    [Abstract] [Full Text] [Related]

  • 3. Streptozotocin-induced diabetes selectively alters the potency of analgesia produced by mu-opioid agonists, but not by delta- and kappa-opioid agonists.
    Kamei J, Ohhashi Y, Aoki T, Kawasima N, Kasuya Y.
    Brain Res; 1992 Feb 07; 571(2):199-203. PubMed ID: 1319265
    [Abstract] [Full Text] [Related]

  • 4. Role of vagal afferents in the antinociception produced by morphine and U-50,488H in the colonic pain reflex in rats.
    Diop L, Rivière PJ, Pascaud X, Dassaud M, Junien JL.
    Eur J Pharmacol; 1994 May 12; 257(1-2):181-7. PubMed ID: 8082700
    [Abstract] [Full Text] [Related]

  • 5. Serotonergic involvement in the antinociceptive action of and the development of tolerance to the kappa-opioid receptor agonist, U-50, 488H.
    Ho BY, Takemori AE.
    J Pharmacol Exp Ther; 1989 Aug 12; 250(2):508-14. PubMed ID: 2547935
    [Abstract] [Full Text] [Related]

  • 6. Roles of mu, delta and kappa opioid receptors in spinal and supraspinal mediation of gastrointestinal transit effects and hot-plate analgesia in the mouse.
    Porreca F, Mosberg HI, Hurst R, Hruby VJ, Burks TF.
    J Pharmacol Exp Ther; 1984 Aug 12; 230(2):341-8. PubMed ID: 6086883
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Effects of morphine in rats treated chronically with U-50,488 H, a kappa opioid receptor agonist.
    Bhargava HN, Ramarao P, Gulati A.
    Eur J Pharmacol; 1989 Mar 21; 162(2):257-64. PubMed ID: 2542058
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Spinal involvement of both dynorphin A and Met-enkephalin in the antinociception induced by intracerebroventricularly administered bremazocine but not morphine in the mouse.
    Tseng LF, Collins KA.
    J Pharmacol Exp Ther; 1993 Sep 21; 266(3):1430-8. PubMed ID: 8103794
    [Abstract] [Full Text] [Related]

  • 12. Disability of development of tolerance to morphine and U-50,488H, a selective kappa-opioid receptor agonist, in neuropathic pain model mice.
    Sounvoravong S, Takahashi M, Nakashima MN, Nakashima K.
    J Pharmacol Sci; 2004 Mar 21; 94(3):305-12. PubMed ID: 15037816
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Blockade of morphine reward through the activation of kappa-opioid receptors in mice.
    Funada M, Suzuki T, Narita M, Misawa M, Nagase H.
    Neuropharmacology; 1993 Dec 21; 32(12):1315-23. PubMed ID: 7908722
    [Abstract] [Full Text] [Related]

  • 15. A selective kappa-opioid agonist, U-50,488H, blocks the development of tolerance to morphine analgesia in rats.
    Yamamoto T, Ohno M, Ueki S.
    Eur J Pharmacol; 1988 Oct 26; 156(1):173-6. PubMed ID: 2850208
    [Abstract] [Full Text] [Related]

  • 16. Cross-tolerance to acute administration of mu and kappa opioid agonists at the spinal cord level in the rat.
    Laurido C, Hernandez A, Perez H.
    Int J Neurosci; 1996 Nov 26; 87(3-4):191-9. PubMed ID: 9003979
    [Abstract] [Full Text] [Related]

  • 17. ATP-gated K(+) channel openers enhance opioid antinociception: indirect evidence for the release of endogenous opioid peptides.
    Lohmann AB, Welch SP.
    Eur J Pharmacol; 1999 Dec 03; 385(2-3):119-27. PubMed ID: 10607867
    [Abstract] [Full Text] [Related]

  • 18. Effects of ibogaine and noribogaine on the antinociceptive action of mu-, delta- and kappa-opioid receptor agonists in mice.
    Bhargava HN, Cao YJ, Zhao GM.
    Brain Res; 1997 Mar 28; 752(1-2):234-8. PubMed ID: 9106462
    [Abstract] [Full Text] [Related]

  • 19. Mu antagonist and kappa agonist properties of beta-funaltrexamine (beta-FNA) in vivo: long-lasting spinal analgesia in mice.
    Qi JA, Heyman JS, Sheldon RJ, Koslo RJ, Porreca F.
    J Pharmacol Exp Ther; 1990 Mar 28; 252(3):1006-11. PubMed ID: 2156986
    [Abstract] [Full Text] [Related]

  • 20. Roles of central and peripheral mu, delta and kappa opioid receptors in the mediation of gastric acid secretory effects in the rat.
    Fox DA, Burks TF.
    J Pharmacol Exp Ther; 1988 Feb 28; 244(2):456-62. PubMed ID: 2831341
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.